InvestorsHub Logo
Followers 31
Posts 2649
Boards Moderated 0
Alias Born 10/28/2013

Re: Amatuer17 post# 160326

Sunday, 07/29/2018 12:03:39 AM

Sunday, July 29, 2018 12:03:39 AM

Post# of 462422
Patent: The way I remember it, Anavex was arguing that there was synergy shown for 2-73 with a very small amount of DZP or similar added. This very small level of dosing probably made any competition for the Sigma 1 Receptor a non issue. It would also make the cost of adding that very small dose of (now generic) DZP (or similar) a non-issue.

That was the final standoff... Anavex claiming this synergy at a very small dose of DZP... and then the patent was finally granted.

I think you will find this history in the "Image Wrapper File" or other records. https://portal.uspto.gov/pair/PublicPair

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News